September 6, 2018 by Michael Zimmerman and Todd Huseby
A.T. Kearney, A.T. Kearney’s “2018 State of Logistics Report”, Michael Zimmerman, Todd Huseby
Issue 08-27-2018, Opinion
The high value of pharmaceutical shipments has traditionally meant that all parties in the chain drug industry were primarily concerned with quality. They needed a reliable, transparent solution. Given that shipping represented a tiny percentage of drug costs, price was a lesser concern. But recently shipping rates have increased sharply. Is there anything the industry
October 9, 2017 by Todd Huseby and Chain Drug Review
A.T. Kearney, A.T. Kearney’s Global Business Policy Council, America@250, Todd Huseby
2017, Issue 10-09-2017, Issues, Opinion
On July 4, 2026, when America marks its 250th birthday, will the nation be stable and prosperous? That is the core question behind America@250 — a multiyear initiative launched by A.T. Kearney, in partnership with The Wall Street Journal. Muhtar Kent of Coca-Cola Co., Chip Bergh of Levi Strauss, Rhonda Vetere of Estée Lauder Cos.,
April 24, 2017 by Todd Huseby, Jim Singer and Chain Drug Review
A.T. Kearney, BAT, Border Adjustment Tax, chain drug operators, chain drug store, Jim Singer, NAFTA, Todd Huseby
2017, Issue 04-24-2017, Issues, Opinion
Staying competitive in the fast-moving chain drug store world is hard enough in the best of times. But things may be about to get even tougher. Chain drug operators with significant imports, and the corresponding consumer packaged goods partners, now face potentially significant challenges to their profitability in the form of the uncertainty and mixed-signals
August 3, 2016 by Todd Huseby, Bob O'Meara and Chain Drug Review
A.T. Kearney, Bob O’Meara, community pharmacy, pharmacy retailers, retail pharmacy industry, Todd Huseby
Leading Headlines, Opinion
With massive change in the retail pharmacy industry — including mergers and acquisitions, downward pressure on reimbursement rates, consolidation of payers, and a nascent movement to transform pharmacists into providers — now is a good time to take a step back and look at the big picture. What forces will transform the industry, and which
July 19, 2016 by Todd Huseby, Jason Dombi and Chain Drug Review
A.T. Kearney, digital analytics, digital business model, digital business strategy, Jason Dombi, Todd Huseby
Opinion
Recent studies point to digital as the primary force driving the business and societal changes that are affecting company operations across industries. Because retail and health care are facing the most disruption, North American pharmacies can no longer afford to watch from the sidelines. While leading players are making fundamental changes to their entire organizations
May 3, 2016 by Adam Pressman and Todd Huseby
A.T. Kearney, Adam Pressman, digital marketing, Todd Huseby
Opinion
Marketing is among those operations undergoing a fundamental change in the digital world. Today’s consumer has materially different expectations about how she wants to buy products and services and about how she expects companies to market them to her. In such a dynamic environment, chain drug store executives need to make digital marketing a priority.
August 8, 2014 by Bob O'Meara, Todd Huseby, Jason Dombi and Chain Drug Review
A.T. Kearney, accountable care organization, ACO, Bob O’Meara, e-health, health care, Jason Dombi, pharmacy, retail clinic, telemedicine, Todd Huseby
Issue 08-11-2014, Opinion
It’s Monday morning and you wake up with a throbbing headache, stuffy and dizzy, recognizing that the next thing you absolutely positively need to hear is, “The doctor will see you now.” You roll over in bed, pick up your tablet, open your accountable care organization’s (ACO’s) telemedicine app, and in a few minutes you